Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
ApartmentLove (C.APLV) Integrates OwnerDirect.com with Google to Display Vacation Rental Listings Worldwide (click to learn more)
Argentina Lithium (V.LIT) Announces US$90 Million Investment by Stellantis (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Lexaria Bioscience Corp
LEXX
Alternate Symbol(s):
LEXXW
Healthcare
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is a global innovator in drug delivery platforms. The Company operates through two segments: Intellectual Property and Products. The Company’s patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting oral delivery. The Company’s...
operations involve the development and usage, including licensing, of its DehydraTECH Technology. The Company operates a licensed in-house research laboratory and holds an intellectual property portfolio with approximately 27 patents granted and roughly 50 patents pending worldwide. The Company’s subsidiaries include Lexaria CanPharm ULC, Lexaria CanPharm Holdings Corp., PoViva Corp., Lexaria Hemp Corp., Kelowna Management Services Corp., Lexaria Nicotine LLC and Lexaria Pharmaceutical Corp.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:LEXX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 09, 2023 9:15am
New Press Release - Lexaria's DehydraTECH-Nicotine Faster than ZYN and on!
(TheNewswire) DehydraTECH-Nicotine reaches maximum blood saturation levels faster than world-leading brands from Swedish Match and Altria in human study NIC-H22-1 Noteworthy superior subjective performance characteristics also observed Kelowna, British Columbia – TheNewswire - August 9, 2023...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 02, 2023 9:10am
New Press Release - Lexaria's Plans to Study Weight Loss and Diabetes Control in a Human Clinical Study with DehydraTECH-CBD
(TheNewswire)Kelowna, British Columbia - TheNewswire - August 2, 2023 - Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to report its intention to conduct a human clinical study to examine DehydraTECH-CBD...
read article.
ApartmentLove Integrates OwnerDirect.com with Google to Display Vacation Rental Listings Worldwide
posted Sep 28, 2023 9:00am by
ApartmentLove Inc.
-
|
ApartmentLove is thrilled to announce the successful integration of OwnerDirect.com with Google to showcase vacation rental listings on search results. This integration means Short-Term Vacation Rental properties advertised on OwnerDirect.com can be showcased in Google search results for vacation rental queries in real-time to users from around the world for no added cost. ...read more
(1555)
•••
lscfa
X
Comment by
lscfa
on Jul 28, 2023 1:20pm
RE:LEXX creates new CPG Subsidiary and updates Nicotine Study
zzzzzzzzzzzzzzzzz
(15)
•••
Yowza123
X
Post by
Yowza123
on Jul 28, 2023 9:52am
LEXX creates new CPG Subsidiary and updates Nicotine Study
https://ir.lexariabioscience.com/news-events/press-releases/detail/219/lexaria-incorporates-new-subsidiary-for-cpg-products-and
(17)
•••
whytestocks
X
Post by
whytestocks
on Jul 20, 2023 12:45pm
Lexaria Bioscience Corp. (NASDAQ: LEXX) Is Building a Robust
NEWS: $LEXX Lexaria Bioscience Corp. (NASDAQ: LEXX) Is Building a Robust and Growing International Patent Portfolio for DehydraTECH(TM) in Support of Commercial OpportunitiesLexaria is a global
...more
(27)
•••
shawk
X
Post by
shawk
on Jul 19, 2023 9:58am
New Patent
New Nicotine Patent
(1555)
•••
lscfa
X
Comment by
lscfa
on Jul 11, 2023 11:52pm
RE:Lexaria Bioscience Corp. (NASDAQ: LEXX) - A Zacks Update
$12 US fair value.... https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_06262023_LEXX_Vandermosten.pdf
(17)
•••
whytestocks
X
Post by
whytestocks
on Jul 11, 2023 9:00pm
Lexaria Bioscience Corp. (NASDAQ: LEXX) - A Zacks Update
Just In: $LEXX Lexaria Bioscience Corp. (NASDAQ: LEXX) - A Zacks UpdateLexaria just released its mid-year update, highlighting its key milestones so far and its objectives going forward, summarized in
...more
(15)
•••
Yowza123
X
Post by
Yowza123
on Jun 22, 2023 11:52am
Lexaria's Research Publicized in Peer Reviewed Articles
https://ir.lexariabioscience.com/news-events/press-releases/detail/217/lexarias-groundbreaking-research-into-dehydratech-cbd
(15)
•••
Yowza123
X
Post by
Yowza123
on May 23, 2023 3:12pm
DehydraTECH Reduces Pro-Inflammatory Biomarkers
https://ir.lexariabioscience.com/news-events/press-releases/detail/213/lexaria-discovers-that-dehydratech-cbd-treatment-in cut and paste link ...please and thanks
(15)
•••
Yowza123
X
Post by
Yowza123
on Apr 24, 2023 9:42am
LEXX awards contract for FDA clinical study
https://ir.lexariabioscience.com/news-events/press-releases/detail/206/lexaria-awards-cro-contract-for-upcoming-u-s-phase-1b
(15)
•••
Yowza123
X
Post by
Yowza123
on Apr 20, 2023 10:22am
LEXX receives 4 new patents
https://ir.lexariabioscience.com/news-events/press-releases/detail/205/lexaria-is-receiving-four-new-patents
(1555)
•••
lscfa
X
Post by
lscfa
on Apr 15, 2023 12:12pm
Fins on sedar
As of February 28, 2023, the Company had cash on hand of approximately $3.3m to settle $223k in current liabilities. The Company believes this is sufficient to fund our expected R&D and operating
...more
(1555)
•••
lscfa
X
Post by
lscfa
on Mar 22, 2023 10:57pm
mgmt circ on sedar
CEO is over paid....2022.... $483,874.....2021..... $494,116 ------ President is overpaid ..2022... $439,712...2021...$410,274
(108)
•••
ranman
X
Comment by
ranman
on Mar 08, 2023 5:41pm
RE:Lexaria in NEWS!
You posted the wrong link. If you did that intentionally that's a scummy way of getting hits to your website. Otherwise can you post the correct link please? I noticed you did the same thing on
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Advanced Project Opportunities Throughout Argentina’s Lithium Triangle
Electric Dreams: Transforming the World with a Clean Energy Future - Download Free Report Now!
Energy Co. Announces Low Dilutive Development Capital Raise
Metallurgical Test Program at Los Cuyes Yielded Excellent Gold Recoveries
Eminent Gold has signed a purchase & sale agreement with Orogen Royalties for property in Nevada
NorthStar Gaming inks $10 million deal with Playtech to expand into the rest of Canada
Discover Lithium Recycling at the Epicentre of the Largest EV Build Out in US History
Total revenue Increased 47% with Two +28% Dividend Increases in 6 Months – Learn More Here
Copper Exploration Company is on the Edge of a Big Discovery
Private Placement: Ready for a Golden Opportunity in Ghana and Canada?